[Neurometabolic therapy of diabetic neuropathy].
Medvedeva
L A
LA
Gnezdilov
A V
AV
Zagorul'ko
O I
OI
Syrovegin
A V
AV
Samoĭlova
N V
NV
Slashchuk
Iu I
IuI
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use*; D000975:Antioxidants / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism; D002220:Carbamazepine / Q000627:therapeutic use; D003929:Diabetic Neuropathies / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy / Q000209:etiology; D010431:Pentoxifylline / Q000627:therapeutic use; D010847:Picolines / Q000627:therapeutic use; D013831:Thiamine / Q000031:analogs & derivatives / Q000627:therapeutic use; D008063:Thioctic Acid / Q000627:therapeutic use; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D018712:Analgesics, Non-Narcotic; D000975:Antioxidants; D001786:Blood Glucose; D010847:Picolines; D014665:Vasodilator Agents; C070020:emoxypine succinate; D002220:Carbamazepine; D008063:Thioctic Acid; D010431:Pentoxifylline; D013831:Thiamine; C013835:benphothiamine